Yostra Labs Private Limited

Background

Founded in 2014, Yostra Labs Private Limited is a Bengaluru-based healthcare technology company dedicated to developing innovative, affordable, and sustainable solutions for cost-sensitive markets. The company's mission is to enhance healthcare accessibility and affordability through cutting-edge technology, focusing on addressing critical healthcare challenges.

Key Strategic Focus

Yostra specializes in diagnostic and advanced wound care products for diabetic foot conditions. Their core objectives include developing smart, sustainable solutions tailored for cost-sensitive markets, with a focus on enhancing healthcare accessibility and affordability. The company targets the diabetic foot care market, aiming to provide comprehensive screening and treatment solutions.

Financials and Funding

Yostra has raised a total of $543,000 in funding over multiple rounds. In August 2022, the company secured ₹4 crore in a seed round led by the Indian Angel Network (IAN), Impact Innovators and Entrepreneurs Foundation (Villgro Innovations Foundation), and the Centre for Cellular and Molecular Platform. The funds are intended to expand the internal sales and marketing team, increase market reach, commercialize the product line, and scale up manufacturing.

Pipeline Development

Yostra's key products include:

NEURO TOUCH: A comprehensive point-of-care screening device for small and large fiber peripheral neuropathy, aiding in the diagnosis of diabetic neuropathy.

VELOX CARE: An advanced wound care solution utilizing topical warm oxygen therapy for the treatment of chronic wounds like diabetic foot ulcers.

NEURO KIT: A diagnostic tool for diabetic peripheral neuropathy.

These products are currently available in the market, with ongoing efforts to expand their reach and impact.

Technological Platform and Innovation

Yostra's innovation is exemplified by its proprietary technologies:

NEURO TOUCH: A 4-in-1 device that simplifies the screening process for diabetic peripheral neuropathy, enabling comprehensive assessments with a single handheld, portable, battery-operated device.

VELOX CARE: Utilizes topical warm oxygen therapy to accelerate the healing of chronic wounds, representing a novel approach in wound care management.

The company holds multiple patents related to these technologies, underscoring its commitment to innovation in diabetic foot care.

Leadership Team

Vinayak Nandalike: Founder and CEO with 20 years of experience in product development, management consultancy, and entrepreneurship.

Dr. Sanjay Sharma: Co-founder and founder of APTA Footsecure, with 18 years of experience in providing healthcare for the masses.

Neeta Kowdi: R&D Head with a Master's degree in Power Electronics and over 5 years of experience in electronic hardware design and production.

Srivatsa: Sales and Marketing Head with over 6 years in the medical device industry, focusing on revenue growth and strategic sales planning.

Ram Mohan Rao: Co-founder and CFO, an alumnus of the National University of Singapore with experience in product development in structured financial assets and risk management.

Dr. Maruthy: Co-founder and Scientific Advisor, Professor and Head of the Department of Physiology at Narayana Medical College, Nellore.

Mukul Bagga: Advisor with over 25 years of experience in healthcare, holding commercial leadership roles across various sectors, including pharmaceuticals and diagnostics.

Supradeep: Head of Pre and Post Sales, specializing in developing strategic partnerships and delivering comprehensive after-sales support.

Leadership Changes

In June 2023, Virupaksha Kakubal Math was appointed as a Director, bringing additional expertise to the leadership team.

Competitor Profile

Market Insights and Dynamics: The diabetic foot care market is experiencing significant growth due to the increasing prevalence of diabetes worldwide. Innovations in diagnostic and treatment solutions are driving market expansion, with a focus on improving patient outcomes and reducing healthcare costs.

Competitor Analysis:

Trivitron Healthcare: A Chennai-based company offering a wide range of medical devices and diagnostic solutions.

Skanray Technologies: A Mysore-based medical technology company specializing in high-frequency X-ray imaging systems and critical care devices.

Both competitors focus on broader medical device markets, while Yostra's specialization in diabetic foot care provides a distinct competitive advantage.

Strategic Collaborations and Partnerships

Yostra has established significant collaborations with investors and accelerators, including:

Indian Angel Network (IAN): Provided seed funding to support product commercialization and market expansion.

Villgro Innovations Foundation: Supported Yostra's mission to develop affordable healthcare solutions.

Centre for Cellular and Molecular Platforms: Assisted in scaling up manufacturing and enhancing product development.

Operational Insights

Yostra's strategic focus on diabetic foot care, combined with its innovative product offerings, positions the company as a leader in this niche market. The company's commitment to affordability and accessibility aligns with the needs of cost-sensitive markets, providing a competitive edge over broader-focused competitors.

Strategic Opportunities and Future Directions

Yostra aims to expand its market reach by increasing the adoption of its products across India and exploring international markets. The company plans to invest in research and development to introduce new products and enhance existing ones, further solidifying its position.